The Department of Defense is offering the PRMRP Clinical Trial Award to swiftly execute clinical trials that could significantly impact specified diseases. The trials can assess new products, drugs, devices, guidance, and innovative technologies. Projects may vary in scale from small proof-of-concept trials to large-scale efficacy studies, focusing on the medical needs of military members, Veterans, and beneficiaries. Military or Veteran participation is optional. The application deadline for this grant is September 27, 2018.
Opportunity ID: 304722
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH18PRMRPCTA |
| Funding Opportunity Title: | DoD PRMRP Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 04, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 27, 2018 |
| Current Closing Date for Applications: | Sep 27, 2018 |
| Archive Date: | Oct 27, 2018 |
| Estimated Total Program Funding: | $48,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY18 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the healthcare needs of military Service members, Veterans, and/or beneficiaries; however, the use of military or Veteran populations is not required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 304722 Full Announcement-FY18 PRMRP CTA -> PRMRP_FY18_CTA_PA_GG.PDF
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00241800 | May 04, 2018 | Sep 27, 2018 | View |
Package 1
Mandatory forms
304722 RR_SF424_2_0-2.0.pdf
304722 AttachmentForm_1_2-1.2.pdf
304722 RR_PersonalData_1_2-1.2.pdf
304722 RR_KeyPersonExpanded_2_0-2.0.pdf
304722 RR_Budget_1_4-1.4.pdf
304722 PerformanceSite_2_0-2.0.pdf
Optional forms
304722 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
